Latest News
Literature Review
mRNA vaccine cuts COVID-related Guillain-Barré risk
“While Guillain-Barré is extremely rare, people should be aware that having a COVID infection can increase their risk of developing the disorder,...
News from the FDA/CDC
FDA warns of hidden ingredients in arthritis, pain products
“I don’t know if this was intentional, but it seems suspicious that a product marketed to reduce joint pain and inflammation contains prescription...
Conference Coverage
Subcutaneous ocrelizumab, ofatumumab ‘reassuring’ in MS
The study “makes me feel pretty comfortable that regardless of where you’re delivering the therapy, IV or subcutaneously, it’s getting in there...
Conference Coverage
Promising topline phase 2 results for novel oral Alzheimer’s drug
The data suggest that a “high plasma pTau-217/non–pTau-217 ratio, a marker of AD pathology, likely defines an AD population responsive to T3D-959...
Feature
Massive databases unleash discovery, but not so much in the U.S.
Vast medical databases have connected dots where smaller randomized trials could not. But the United States has a long way to go.
Conference Coverage
‘Frame running’ may help boost physical activity in MS
‘Frame running’ uses a three-wheeled frame with a saddle and body supports but no pedals to allow individuals with disabilities and balance...
From the Journals
Hitting the snooze button may provide cognitive benefit
“There is no reason to stop snoozing in the morning if you enjoy it, at least not for snooze times around 30 minutes.”
News from the FDA/CDC
New meningococcal vaccine wins FDA approval
The vaccine “has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest...
Feature
Employment vs. private practice: Who’s happier?
“It used to be that fewer hospitals offered employment, so private practice was the way to go. Now, there are fewer privates because hospitals and...
Conference Coverage
MS, DMTs, and pregnancy: Beware of over-caution regarding treatment
Don’t be too quick to stop therapy or too slow to restart it, researcher tells ECTRIMS audience.
Conference Coverage
Wearable devices show promise in monitoring multiple sclerosis
Further analysis may allow the prediction of “relevant changes throughout the course of multiple sclerosis.”